Insider Transactions Reported by 21 Insiders of Moderna, Inc.

Symbol
MRNA on Nasdaq
Location
Cambridge, MA

Insiders trading volume in the past year

Moderna, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Stephane Bancel Chief Executive Officer, Director $243M +$5M +2.11% 11 Dec 2025
NOUBAR AFEYAN Director $183M -$703K -0.38% 11 Dec 2025
Stephen Hoge President $46.6M 01 Dec 2025
PAUL SAGAN Director $15.7M +$1M +6.84% 30 Apr 2025
Stephen Berenson Director $2.52M 03 May 2024
Arpa Garay Chief Commercial Officer $1.52M 05 Dec 2023
James M. Mock Chief Financial Officer $1.4M 05 Dec 2025
Shannon Thyme Klinger Chief Legal Officer $1.39M 05 Dec 2025
Juan Andres Chief Technical Operations and Quality Officer $1.33M 28 Dec 2022
David Meline Chief Financial Officer $645K 09 Aug 2022
Paul Burton Chief Medical Officer $542K 04 Nov 2022
ELIZABETH G. NABEL Director $193K 30 Apr 2025
Sandra Horning Director $174K 30 Apr 2025
David M. Rubenstein Director $134K 05 Aug 2025
Abbas Hussain Director $107K -$22.6K -17.4% 09 Dec 2025
LORI M. HENDERSON General Counsel and Secretary $93.6K 27 May 2021
Francois Nader Director 30 Apr 2025
Elizabeth E. Tallett Director 30 Apr 2025
ROBERT LANGER Director 06 May 2024
Jorge M. Gomez Officer 09 May 2022
Tal Zvi Zaks Chief Medical Officer 30 Jun 2021

Recent Insider Transactions by Companies or Individuals for Moderna, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.